Scanogen INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersWindsor Mill, MD
SAM.gov UEIJK9PMLM41J77
Scanogen develops the SMART-ID assay, a diagnostic test that identifies pathogens directly from whole blood using Single Molecule And Rapid Tethering (SMART) technology, intended for sepsis diagnosis. The assay is currently under development and has received FDA Breakthrough Device Status. The company serves the clinical diagnostics industry, specifically addressing sepsis diagnosis where current methods rely on blood cultures that take one or more days.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Scanogen INC. | Windsor Mill | MD | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


